Keywords: reneuron, reports, positive, early, data, ctx, pad

ReNeuron reports positive early data with CTX in PAD

Article | 06 April 2009

Print This

UK stem cell firm ReNeuron has reported positive preclinical efficacy data with its lead CTX stem cell line in a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in